These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 31721164)

  • 1. A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.
    Liu C; Guo T; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Califano JA
    Cancer; 2020 Feb; 126(4):737-748. PubMed ID: 31721164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.
    Liu C; Guo T; Xu G; Sakai A; Ren S; Fukusumi T; Ando M; Sadat S; Saito Y; Khan Z; Fisch KM; Califano J
    Clin Cancer Res; 2018 Oct; 24(20):5123-5132. PubMed ID: 29945995
    [No Abstract]   [Full Text] [Related]  

  • 3. LOXL2-enriched small extracellular vesicles mediate hypoxia-induced premetastatic niche and indicates poor outcome of head and neck cancer.
    Zhu G; Wang L; Meng W; Lu S; Cao B; Liang X; He C; Hao Y; Du X; Wang X; Li L; Li L
    Theranostics; 2021; 11(19):9198-9216. PubMed ID: 34646366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.
    Fukumoto I; Kikkawa N; Matsushita R; Kato M; Kurozumi A; Nishikawa R; Goto Y; Koshizuka K; Hanazawa T; Enokida H; Nakagawa M; Okamoto Y; Seki N
    J Hum Genet; 2016 Feb; 61(2):109-18. PubMed ID: 26490187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated exosomal lysyl oxidase like 2 is a potential biomarker for head and neck squamous cell carcinoma.
    Sanada T; Islam A; Kaminota T; Kirino Y; Tanimoto R; Yoshimitsu H; Yano H; Mizuno Y; Okada M; Mitani S; Ugumori T; Tanaka J; Hato N
    Laryngoscope; 2020 May; 130(5):E327-E334. PubMed ID: 31219623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma.
    Lv GQ; Zou HY; Liao LD; Cao HH; Zeng FM; Wu BL; Xie JJ; Fang WK; Xu LY; Li EM
    Biochem Cell Biol; 2014 Oct; 92(5):379-89. PubMed ID: 25275797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoids Promote Progression of HPV-Positive Head and Neck Squamous Cell Carcinoma via p38 MAPK Activation.
    Liu C; Sadat SH; Ebisumoto K; Sakai A; Panuganti BA; Ren S; Goto Y; Haft S; Fukusumi T; Ando M; Saito Y; Guo T; Tamayo P; Yeerna H; Kim W; Hubbard J; Sharabi AB; Gutkind JS; Califano JA
    Clin Cancer Res; 2020 Jun; 26(11):2693-2703. PubMed ID: 31932491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation.
    Dixit R; Kemp C; Kulich S; Seethala R; Chiosea S; Ling S; Ha PK; Duvvuri U
    Sci Rep; 2015 Nov; 5():16657. PubMed ID: 26563938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ELOVL6 promotes the progression of head and neck squamous cell carcinoma via activating WNT/β-catenin pathway.
    Wang R; Liu X; Li X; Qian M; Yang X; Jiang Q; Wang Y; Liu H; Chen J; Wang X; Gong L
    Mol Carcinog; 2024 Jun; 63(6):1079-1091. PubMed ID: 38426809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative computational analysis of transcriptional and epigenetic alterations implicates DTX1 as a putative tumor suppressor gene in HNSCC.
    Gaykalova DA; Zizkova V; Guo T; Tiscareno I; Wei Y; Vatapalli R; Hennessey PT; Ahn J; Danilova L; Khan Z; Bishop JA; Gutkind JS; Koch WM; Westra WH; Fertig EJ; Ochs MF; Califano JA
    Oncotarget; 2017 Feb; 8(9):15349-15363. PubMed ID: 28146432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PHF5A regulates the expression of the DOCK5 variant to promote HNSCC progression through p38 MAPK activation.
    Liu C; Li G; Zheng S; She L; Lu S; Wang Y; Huang D; Zhang X; Sun L; Liu Y; Qiu Y
    Biol Direct; 2023 Jul; 18(1):39. PubMed ID: 37434235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of lncRNA WWTR1-AS1 associates with tumor aggressiveness and unfavorable survival in head-neck squamous cell carcinoma.
    Li J; Li Z; Wu Y; Diao P; Zhang W; Wang Y; Yang J; Cheng J
    J Cell Biochem; 2019 Oct; 120(10):18266-18277. PubMed ID: 31172583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas.
    Rost T; Pyritz V; Rathcke IO; Görögh T; Dünne AA; Werner JA
    Anticancer Res; 2003; 23(2B):1565-73. PubMed ID: 12820424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of potential roles of a new LOXL2 splicing variant using network knowledge in esophageal squamous cell carcinoma.
    Wu BL; Lv GQ; Zou HY; Du ZP; Wu JY; Zhang PX; Xu LY; Li EM
    ScientificWorldJournal; 2014; 2014():431792. PubMed ID: 25254241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-κB and stat3 transcription factor signatures differentiate HPV-positive and HPV-negative head and neck squamous cell carcinoma.
    Gaykalova DA; Manola JB; Ozawa H; Zizkova V; Morton K; Bishop JA; Sharma R; Zhang C; Michailidi C; Considine M; Tan M; Fertig EJ; Hennessey PT; Ahn J; Koch WM; Westra WH; Khan Z; Chung CH; Ochs MF; Califano JA
    Int J Cancer; 2015 Oct; 137(8):1879-89. PubMed ID: 25857630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinoma.
    Haque SU; Niu L; Kuhnell D; Hendershot J; Biesiada J; Niu W; Hagan MC; Kelsey KT; Casper KA; Wise-Draper TM; Medvedovic M; Langevin SM
    Head Neck; 2018 Jul; 40(7):1555-1564. PubMed ID: 29575229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Fukumoto I; Kikkawa N; Matsushita R; Mataki H; Mizuno K; Okamoto Y; Seki N
    J Hum Genet; 2017 Jan; 62(1):113-121. PubMed ID: 27169691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus associated XPF deficiency increases alternative end joining and cisplatin sensitivity in head and neck squamous cell carcinoma.
    Zuo N; Ma L; Liu T; Hu W; Luo Y; Meng H; Ren Q; Deng Y; Wei L; Liu Q
    Oral Oncol; 2023 May; 140():106367. PubMed ID: 36996606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression.
    Martin A; Salvador F; Moreno-Bueno G; Floristán A; Ruiz-Herguido C; Cuevas EP; Morales S; Santos V; Csiszar K; Dubus P; Haigh JJ; Bigas A; Portillo F; Cano A
    EMBO J; 2015 Apr; 34(8):1090-109. PubMed ID: 25759215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.